Global Response Aid (GRA) is a 50%-50% Joint venture between Agility, one of the world’s leading logistics companies and AiPharma, an innovative pharma research, development and commercialization company based in Dubai.
GRA delivers innovative, effective healthcare solutions through a range of pharmaceutical products and technology platforms...
Building the
safer world
GRA Team
Mitch Wilson,
CEO
More than 30 years of senior management experience in Logistics, Threat Management and Security
Alex Gadotti,
CFO
Executive and entrepreneur with more than 30 years experience in Management, M&A, Strategy Consulting and Pharma.
Mary O’Brien,
CMO
Over 20 years of experience in the healthcare sector, having worked for several pharmaceutical and medical companies, as well as establishing a number of healthcare businesses.
Partners
Agility, shareholder and logistic partner for the distribution of the pharma products
NAS, part of the Agility group, NAS supports the development and implementation of MUNA worldwide
Appili, Therapeutics, a key partner in the development and clinical trials of Avigan in the United States and Canada.
Dr. Reddy’s Laboratories, a leading generic pharma company based in India with worldwide production and distribution site, Dr.Reddy is the co-license holder of Avigan working alongside with GRA to manufacture and distribute Avigan
FUJI Film Toyama, Originator of Avigan, Fuji cooperates with GRA in manufacturing the drug substance and drug products and in providing the originator technical expertise on Avigan
Clinic Design, A leading CRO in Europe, based in Bulgaria, Clinic Design supports the Clinical Trials and the drug development program for GRA
AVIGAN® / REEQONUS™
(Favipiravir)
AVIGAN® / REEQONUS™ (Favipiravir) is a broad-spectrum oral antiviral originally developed by FUJIFILM Toyama Chemical Co., Ltd. (FFTC) and approved in Japan as a treatment and stockpile countermeasure for pandemic influenza. Favipiravir disrupts viral replication by acting directly on the viral RNA polymerase enzyme.
Favipiravir has been used extensively in many countries since the start of the pandemic, either as an approved drug or as a compassionate treatment. More than half million people have been treated with Favipiravir, either in the generic form or in the original Avigan formulation.
AVIGAN® / REEQONUS™
Avigan is used / approved
Revolutionary blockchain technology trusted by governments and organisations globally to ensure authenticity of Covid-19 test results and vaccine status.
MUNA / IoT PCR
MUNA System Features
Partners
Serving passengers on
Muna App
The MUNA app is a one-stop solution for COVID-19 testing and vaccination booking, verification and certification, a secure digitized pass ensuring users can resume daily activity with confidence.
Download the app and complete a one-time KYC process and benefit from multiple partners in our ecosystem accepting MUNA as the gold standard in digital identification and certification when it comes to COVID testing.
Help prevent the spread of COVID-19
Terms and conditions
Privacy and policy
Modern Slavery Policy
Download MUNA app today to have one-stop solution for COVID-19 testing and vaccination booking, verification and certification.
Copyrights 2026 “Global Response AID”
